Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722008 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket



The Lifestyle Drugs Outlook To 2008: Unlocking New Value In Well-Being
Business Insights, Oct 2003, Pages: 246


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

The lifestyle drugs market is currently worth a phenomenal $23bn to boost its value, pharmaceutical companies are actively searching for new lifestyle products and conditions. The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being, provides a timely market update, examining leading products and pipeline prospects in seven key lifestyle drug sectors, and is supported by forecasts to 2008. Today's R&D is influenced as much by commercial unmet needs as it is by clinical opportunities and chance. Pharmaceutical companies must react quickly to these needs if they are to reap greater financial returns. This report can help you to assess the premium associated with different lifestyle drug markets and identify the potential for higher volume sales. Armed with this information your company can formulate winning lifestyle drug development and marketing strategies, and secure a strong competitive position within this market.



Customers who bought this item also bought

Female Sexual Dysfunction: Prescription Drug Pipeline Overview 2007

Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs

Stakeholder Opinions: Female Sexual Dysfunction - Results From Datamonitors 2005 Physician Survey

U.S. Sexual Dysfunction Medication Markets

Major Milestones: Female Sexual Dysfunction

Female Sexual Dysfunction Therapy Area Pipeline Report

Strategic Perspectives: Female Sexual Dysfunction - Are Physicians and Patients Ready For a Female Viagra?

Male and female sexual dysfunction: Blockbuster indication for multiple pharmacological targets

Womens Health Female Sexual Dysfunction

Erectile Dysfunction Therapy Area Pipeline Report

The World Market For Sexual Disorders, 2005-2012: Traversing New Frontiers in Sexual Chemistry

The Lifestyle Drugs Outlook To 2007: Challenges And Opportunities In A High-Profile Growth Market



Top of page


   All rights reserved. � Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds